Menu visibility control

Video

Events

Startup Surgery

Most Recent

Need to Know

Here’s how your tech firm can exploit the podcasting revolution

Investments

Cheshire-based mobile app SurveyMy gets £2m

The Week in Tech

A £12m series B, a £57.5m fund for Northern SMEs, a hoverbike and more in The Week in Tech

Press Releases

Software testing leader TestPlant appoints Dr. John Bates as CEO
CreditLadder appoints Proptech Expert Sheraz Dar as new CEO
Hermit: A Startup With New Ideas About Office Space

Bristol-based Micrima raises £2.6m to improve breast screening

breast screening
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Micrima, a Bristol-based breast imaging tech company, has raised £2.6m in funding from pre-existing and new investors.

Founded in 2006, the company’s patented MARIA technology aims to make breast screening safer, more comfortable and more accessible to a larger proportion of the female population.

The round drew in support from re-investing shareholders including Technology Venture Partners LLP, Swarraton Partners, and the Angel CoFund. The University of Bristol Enterprise Fund has been welcomed as a new investor.

How to secure funding from Tim Mills, investment director at the Angel CoFund

Roy Johnson, founder and executive chairman of Micrima, said: “Breast cancer is the most common cause of death in women between the ages of 35 and 55 in Europe and the leading cause of death for women in many countries. The problem is that many tumours are not discovered early enough, largely due to the difficulty in discriminating between cancers and dense tissue using current imaging technology.”

The firm says it will use the funding to support accelerated development of its MARIA technology, initially pioneered at the University of Bristol, with plans to start the commercialisation of its first system towards the end of this year.

“Using harmless radiowaves, the MARIA imaging system is capable of detecting tumours in dense tissue and allows routine and repeated scanning without any of the safety or comfort concerns associated with x-ray mammography. The process takes less than five minutes and avoids painful breast compression,” Johnson continued.

Tim Mills, investment director at the Angel CoFund, commented: “We originally invested in Micrima because we knew we’d found an extremely capable team working with some very interesting technology in a sector with considerable opportunity for innovation. The team has really delivered on our expectation in the last couple of years and we’re very happy to be supporting them again through this next phase of development.”

Enter your e-mail address to receive updates straight to your inbox

* indicates required
Send me news on...
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Editor's picks

podcasting revolution

Here’s how your tech firm can exploit the podcasting revolution
posted 1 hour ago

Lee Evans - SurveyMe

Cheshire-based mobile app SurveyMy gets £2m
posted 2 hours ago

TWIT - Emily 23.02.17

A £12m series B, a £57.5m fund for Northern SMEs, a hoverbike and more in The Week in Tech
posted 5 hours ago

Team_Monzo

Challenger bank Monzo announces £19.5m investment
posted 24 hours ago

hostmaker

Hostmaker raises £5m Series A from French VC firm Ventech
posted on February 23, 2017

caspar

EXCLUSIVE: AR startup Zappar lands $3.75m Series A
posted on February 23, 2017